535例婴儿腹泻病例临床资料流行病学分析

对535例婴儿腹泻病例的临床资料进行了流行病学分析。年龄最小的1个月，最大的2岁，男、女比例为1．66：1。婴儿腹泻的好发年龄为7个月至2岁(占总数的80．56％)。其原因可能是7个月龄以上的婴儿从单纯母乳喂养普遍转入添加辅食，和外界接触增多，其免疫机能尚未健全之故。本组病例来源于城镇和农村的比例为1．14：1，城、乡病例数无明显差别，这与以往国内报道的情况有所不同。可能是与我国实施计划生育后该地区农村环境与家庭卫生状况改善，人们的卫生保健意识提高有关。婴儿腹泻的好发季节多见于秋末冬初(占总数的85％)。这与国内报道的发生季节规律基本上相一致。临床特征其起病多突然，无明显诱因。粪便性状均为水样和稀便，无脓血便。实验室粪检均未找到霍乱弧菌。根据腹泻与其他疾病关系分为三类：①单纯性腹泻；②Ⅱ营养不良并腹泻；③支肺炎并腹泻。临床治疗选用中药双黄连(Berberini Sybrochioridum)加5％糖盐水静脉点滴，并用东莨菪碱(Scopolamima)足三里穴位封闭，其效果相当显著。特别是对单纯性腹泻在2～3天内即可100％痊愈。。     

啮齿类和兔类实验动物细菌检测计算机系统简介

本文介绍对啮齿类和兔类实验动物细菌检测计算机系统软件的开发方法、步骤及功能，并论证开发该系统的必要性和可行性。     

炉甘石洗剂的配制及稳定性观察

本文采用分散法制备炉甘石洗剂观察其稳定性。评价几种稳定剂对炉甘石洗剂的混悬效果或絮凝效果,从中找到了适用于炉甘石洗剂较好的助悬剂或絮凝剂。     

活血逍膨汤治疗慢性布卡综合征10例

慢性布卡综合征(BCS)是因肝静脉主干或肝段下腔静脉阻塞引起门静脉和下腔静脉高压的一组临床表现,如肝、脾肿大,胸腹壁静脉曲张,顽固性腹水或下肢水肿等。随着检查技术的进步,本病发现率有逐年增加的趋势。西医治疗BCS主要靠外科手术解除血管中的梗阻,改善症状。一般认为,BCS仅极少数可自行缓解,绝大多数病情呈进行性加重,预后不良。近年来我们重用活血化瘀药组成活血消臌汤治疗10例,取得了较好疗效,现报告如下。     

经络导平仪治疗脱毒后睡眠障碍的临床分析

目的 研究经络导平仪治疗脱毒后睡眠障碍的临床疗效观察。方法 对78例脱毒治疗约8～10天后，尿吗啡检验阴性的海洛因依赖者停用镇静催眠药，用经络导平仪，根据中医针灸疗法，辨证配穴原则治疗，每日1次，每次30min，1疗程10天。结果 治愈26例，占治疗人数33．3％；好转47例，占治疗人数60．2％；未愈5例，占治疗人数6％。结论 经络导平仪治疗脱毒后睡眠障碍方面能够尽快改善入睡困难、易醒、醒后不易入睡、多梦症状，延长睡眠时间、促进醒后精力恢复。有助于减轻稽延性戒断症中焦虑、抑郁症状，提高戒毒治疗效果和患者操守率。     

后牙残根残冠的修复

后牙残根残冠在临床上非常多见，以往常采取拔除后行义齿修复。近年来由于根管治疗技术和修复技术的提高，使许多后牙残根残冠得到了保存。本回顾分析了具有完整随访资料的120例病人共142颗后牙的修复情况。效果满意。报道如下：[第一段]     

环戊硫酮治疗干眼的临床疗效评价

Objective To investigate anethol trithione therapic efficiency on dry eye. Methods It was a prospective random double-blind controlled study. Eighty cases diagnosed dry eye in Ocular Surface Out-patient Clinic of Xiamen University Affiliated Xiamen Eye Center from 2006 to 2008 were divided into two groups: anethol trithione group and control group, 40 cases in each group. Every group was then divided into two subgroups: weak dry eye subgroup, middle and severe dry eye subgroup. All groups had been added with 0.05% refresh drops. All patients had been detected and evaluated by subjective symptoms of dry eye, visual acuity,corneal fluorescent staining(F1), break-up time(BUT) and Schirmer Ⅰ test (SⅠT) at pre-therapy and 3,7,28 d of post-therapy. All groups had been compared and analyzed by F test and sample mean difference (SMD) or median difference (MD) comparison between pre-therapy and post-therapy. Results Except of tear and red eye, the other subjective symptoms of dry eye, F1, BUT and SⅠT of weak dry eye subgroup of both groups had been improved at 7 d after therapy. Only those of middle and severe dry eye subgroup of anethol trithione group had been improved at 7 d after therapy compared with those of pre-therapy: SMD=0.96 (visual tiredness), 1.26 (dry and unsmooth sensation), 0.82 (foreign body sensation), 1.28 (burning sensation), 1.05 (photophobia), 1.48 ( pain ) ; MD=0.30 (visual acuity), 4.00 (F1) ,5.00 (BUT), 5.00 (SⅠT) [F=15.30 (visual tiredness), 15.68 (dry and unsmooth sensation ), 13.56 (foreign body sensation), 20. 91 ( burning sensation ), 18.90 (photophobia), 27.22 ( pain ), 10.54 (visual acuity), 188.21 (F1) ,261.76 (BUT) ,269.05 (SⅠT) ;P<0. 05]. Those of middle and severe dry eye subgroup of control group hadn't significantly been improved at 28 d after therapy: SMD=0.10 (visual tiredness) ,0.16 (dry and unsmooth sensation) ,0.09 (foreign body sensation) ,0.38 ( burning sensation ), 0.24(photophobia) ,0.36 (pain) ,0.23 (red eye) ; MD=0.10 (visual acuity) ,0.50(F1) ,0.50(BUT), 0.50(SⅠT) [F=1.76 (visual tiredness), 1.61 (dry and unsmooth sensation), 1.02 (foreign body sensation),2.39 (burning sensation), 2.42 (photophobia), 2.73 ( pain ), 2.55 ( red eye ), 1.46 ( visual acuity) ,2.35 (F1) ,2.90 (BUT) ,2.76 (SⅠT) ; P>0.05]. SⅠT of anethol trithione group had been improved more significantly after therapy (F=13.77, P<0.05). Conclusion Anethol trithione could significantly improve middle and severe dry eye patients' symptoms and signs whose lacrimal gland function survival and it has clinical application value.     

接触式微波辐射器问世

目前,3450兆赫微波理疗机常采用非接触式大面积照射的辐射器。在进行治疗时,由于泄漏的微波能量影响医务人员的健康,并使病人的非治疗区受到不应有的微波照射。南京大学信息物理系研究量功泄漏能极小的MR-1型接触式微波辐射器,现已通过省级鉴定。该辐射器采用环形微带结构,选用高频陶瓷作基片,N 型同辐接头背面馈电的结构,具有下列优点;1.泄漏能量小于10微瓦/cm~2,远低于国家规定的微波剂量安全标准(50微瓦/cm~2),比输入功率低60分